• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Down 0.49%

    VIVUS Inc. (VVUS)

    -NasdaqGS
    2.27 Down 0.05(1.95%) 2:40PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.31
    Open:2.30
    Bid:2.26 x 12700
    Ask:2.27 x 5600
    1y Target Est:4.50
    Beta:1.76
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:2.23 - 2.31
    52wk Range:2.22 - 5.14
    Volume:695,281
    Avg Vol (3m):1,014,260
    Market Cap:235.14M
    P/E (ttm):N/A
    EPS (ttm):-0.80
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    VVUSDown 1.95%235.14M
    LLYUp 1.66%92.96B
    GSKDown 0.55%100.75B
    PFEUp 1.08%206.96B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.19
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.84
    Quarterly EPS Est (Jun-15) :-0.23
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):-3.74

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback